Nanoviricides Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.38

+0.01 (+0.73%)

As of Jun 30, 10:48 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +2,169.6% upside

Low Target $21.60

Average Target $31.32

High Target $37.71

Current Price $1.38

Current
$1.38

Target
$31.32

$21.60 $31.32 avg $37.71

Scenario Analysis

Bear Case

$21.60

1,465.2%

Low target

Base Case

$31.32

+2,169.6%

Avg target

Bull Case

$37.71

+2,632.6%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.23

-38.1% from high

52-Week Low

$0.85

+62.4% from low

Target vs 52W High

$31.32

+1,304.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%